Evidence map›Paper›PMID 41984924›Full record

ArticlePLoS biology2026

High-throughput characterization of Mycobacterium tuberculosis gene function across diverse conditions.

Kayla M Dinshaw, Katie A Lien, Matthew Knight, Sorel V Yimga Ouonkap, Hualan Liu, David F Savage, Hans K Carlson, Adam M Deutschbauer, Sarah A Stanley

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A new Persister Enrichment Model inbioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kayla M DinshawDepartment of Molecular and Cell Biology, University of California, Berkeley, California, United States of America.
Katie A LienDepartment of Molecular and Cell Biology, University of California, Berkeley, California, United States of America.
Matthew KnightDepartment of Plant and Microbial Biology, University of California, Berkeley, California, United States of America.
Sorel V Yimga OuonkapDepartment of Molecular and Cell Biology, University of California, Berkeley, California, United States of America.
Hualan LiuJoint Genome Institute, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.
David F SavageDepartment of Molecular and Cell Biology, University of California, Berkeley, California, United States of America.
Hans K CarlsonEnvironmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.
Adam M DeutschbauerDepartment of Plant and Microbial Biology, University of California, Berkeley, California, United States of America.
Sarah A StanleyDepartment of Molecular and Cell Biology, University of California, Berkeley, California, United States of America.ORCID https://orcid.org/0000-0002-4182-9048

Funding

METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSISR01AI153197 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DARWIN, KATERINA HERAN, STANLEY, SARAH A · 2020 to 2025
$7.3M
The role of nanocompartments in M. tuberculosis pathogenesisR01AI143722 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI STANLEY, SARAH A · 2019 to 2023
$1.9M
Use of random barcode transposon site sequencing as a tool for identifying nutrient acquisition strategies utilized by Mycobacterium tuberculosis during infection of human macrophagesR21AI191565 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Sarah A Stanley · 2025 to 2026
$413k
NIAID NIH HHS R01 AI143722NIAID NIH HHS R01 AI153197NIAID NIH HHS R21 AI191565
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) is a human bacterial pathogen that establishes chronic infection in the lung. Although the genome of Mtb was sequenced nearly 25 years ago, the genetic basis of Mtb's success as a human pathogen remains to be fully elucidated. Large-scale mutation-based genetic approaches to understanding gene function are hindered by the limited throughput of traditional transposon sequencing strategies used in mycobacteria. To create a resource for determining the function of genes, we generated a pooled random barcode transposon-site sequencing (RB-TnSeq) library in Mtb. A unique 20-nucleotide barcode in the transposon allows for rapid, high-throughput genetic screening without the laborious protocol of standard bacterial TnSeq screens. We performed 95 RB-TnSeq screens on an array of carbon sources, nitrogen sources, stressors, and antibiotics. Using the resulting dataset, we examined phenotypes of pe and ppe genes, a mycobacterial gene family whose function has long been elusive, uncovering 187 novel phenotypes across 37 genes in this family. We propose a pathway for lactate utilization in which the ESX-5 type VII secretion system may export PPE3, facilitating the import of D- and L-lactate into the bacterial cell. Notably, we identify a candidate D-lactate dehydrogenase that may mediate this metabolic capability. Additionally, we find that the proton-pumping NADH dehydrogenase Nuo is required for utilization of propionate, highlighting the metabolic flexibility of Mtb. Lastly, we characterize a novel mutant that confers resistance to the new tuberculosis antibiotic pretomanid. Results from these genetic screens will facilitate the development of additional new hypotheses about the function of uncharacterized genes and will expand our knowledge of Mtb metabolism and resistance to stress.

Indexed as

Genes, BacterialMycobacterium tuberculosisBacterial ProteinsDNA Transposable ElementsGene LibraryHigh-Throughput Nucleotide SequencingHumansMutationPhenotypeType VII Secretion SystemsBacterial ProteinsDNA Transposable ElementsType VII Secretion Systems

Identifiers

PMID41984924
PMCPMC13102306

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.